Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending November 17, 2005. The report serves as a notification of transactions involving Directors, Persons Discharging Managerial Responsibility, or Connected Persons regarding Ordinary Shares of the Company.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is strictly a regulatory notification of share transactions and does not contain financial performance data.
Material Changes
On November 15, 2005, Abacus (GSK) Trustees Limited, acting as trustee for the GlaxoSmithKline Employee Trust ("the GSK Trust"), transferred 4,198 Ordinary Shares to participants in the SmithKline Beecham Employee Share Option Plan 1991. The Company was advised of these transactions on November 16, 2005.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It notes that the GSK Trust is a discretionary trust where all current and former employees are potential beneficiaries. Three directors (Dr J-P Garnier, Dr T Yamada, and Mr J S Heslop) hold interests in the shares held by the GSK Trust in the same capacity as other employees.
Key Facts for Investor Verification
- Transaction Date: November 15, 2005.
- Shares Transferred: 4,198 Ordinary Shares.
- Recipient: Participants in the SmithKline Beecham Employee Share Option Plan 1991.
- Trustee: Abacus (GSK) Trustees Limited.
- Directors with Interests: Dr J-P Garnier, Dr T Yamada, and Mr J S Heslop.